50 participants
To Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of LYNC-101 for Injection in Healthy Adult Participants
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-27
- Start Date:
- 2026-05-28
- Completion:
- 2027-03-19
Conditions
- UC - Ulcerative Colitis
Interventions
- DRUG
No Results Yet